{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:18:32Z","timestamp":1763414312654,"version":"3.45.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zunyi City Science and technology and big data Bureau, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04442-8","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:01:00Z","timestamp":1759161660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When MOGAD mimics MS: diagnostic and therapeutic insights from a unique CNS demyelinating case"],"prefix":"10.1186","volume":"25","author":[{"given":"Ya Lin","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu Cai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"4442_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105034","volume":"79","author":"E Ganelin-Cohen","year":"2023","unstructured":"Ganelin-Cohen E, Shelly S, Schiller Y, et al. Dual positivity for anti-MOG and oligoclonal bands: unveiling unique clinical profiles and implications. Mult Scler Relat Disord. 2023;79:105034. https:\/\/doi.org\/10.1016\/j.msard.2023.105034.","journal-title":"Mult Scler Relat Disord"},{"key":"4442_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105935","volume":"92","author":"AL Neves","year":"2024","unstructured":"Neves AL, Cabral A, Serr\u00e3o C, et al. Blood neutrophils, oligoclonal bands and bridging corticosteroids as predictive factors for MOGAD course: insights from a multicentric Portuguese cohort. Mult Scler Relat Disord. 2024;92:105935. https:\/\/doi.org\/10.1016\/j.msard.2024.105935.","journal-title":"Mult Scler Relat Disord"},{"key":"4442_CR3","doi-asserted-by":"publisher","first-page":"1211776","DOI":"10.3389\/fimmu.2023.1211776","volume":"14","author":"Y Tomizawa","year":"2023","unstructured":"Tomizawa Y, Hoshino Y, Kamo R, Cossu D, Yokoyama K, Hattori N. Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands. Front Immunol. 2023;14:1211776. https:\/\/doi.org\/10.3389\/fimmu.2023.1211776.","journal-title":"Front Immunol"},{"issue":"7","key":"4442_CR4","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/brain\/awz144","volume":"142","author":"M Filippi","year":"2019","unstructured":"Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858\u201375. https:\/\/doi.org\/10.1093\/brain\/awz144.","journal-title":"Brain"},{"key":"4442_CR5","doi-asserted-by":"publisher","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","volume":"13","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022;13:885218. https:\/\/doi.org\/10.3389\/fneur.2022.885218.","journal-title":"Front Neurol"},{"issue":"3","key":"4442_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al. Diagnosis of Myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8.","journal-title":"Lancet Neurol"},{"issue":"8","key":"4442_CR7","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s00415-023-11737-8","volume":"270","author":"A Al-Ani","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. 2023;270(8):4132\u201350. https:\/\/doi.org\/10.1007\/s00415-023-11737-8.","journal-title":"J Neurol"},{"issue":"1","key":"4442_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","volume":"17","author":"S Jarius","year":"2020","unstructured":"Jarius S, Pellkofer H, Siebert N, et al. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients. J Neuroinflammation. 2020;17(1):261. https:\/\/doi.org\/10.1186\/s12974-020-01824-2.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"4442_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WNO.0000000000001684","volume":"42","author":"BK Chwalisz","year":"2022","unstructured":"Chwalisz BK, Levy M. The treatment of myelin oligodendrocyte glycoprotein antibody disease: a state-of-the-art review. J Neuroophthalmol. 2022;42(3):292\u20136. https:\/\/doi.org\/10.1097\/WNO.0000000000001684.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"4442_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","volume":"89","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2):127\u201337. https:\/\/doi.org\/10.1136\/jnnp-2017-316880.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4442_CR11","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1212\/NXI.0000000000000705","volume":"7","author":"S Li","year":"2020","unstructured":"Li S, Ren H, Xu Y, et al. Long-term efficacy of mycophenolate mofetil in myelin oligodendrocyte glycoprotein antibody-associated disorders: a prospective study. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e705. https:\/\/doi.org\/10.1212\/NXI.0000000000000705.","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04442-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04442-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:05:18Z","timestamp":1763409918000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04442-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4442"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04442-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors requested to add the specific department of affiliation 1.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This report has received ethical approval from the Biomedical Research Ethics Committee of the Affiliated Hospital of Zunyi Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent for the publication of their clinical details and any identifying images included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}